MOUNTAIN VIEW, Calif., March 31 /PRNewswire/ -- Based on its recent analysis of the optical technologies market, Frost & Sullivan recognizes Carl Zeiss Meditec with the 2009 North American Frost & Sullivan Market Leadership Award for its optical coherence tomography (OCT) technology for ophthalmic applications. Carl Zeiss Meditec is a pioneer of OCT technology and has launched clinical tools that revolutionized the diagnosis and treatment of eye diseases.
Carl Zeiss Meditec was the first to introduce Time Domain (TD) OCT-based innovative products for retinal, anterior segment/cornea, and glaucoma imaging. More recently, the company introduced the next generation of Fourier Domain (FD) OCT-based product line for ophthalmic applications.
"Multiple start-up companies have introduced promising FD OCT-based products, creating an increasingly competitive dynamic," says Frost & Sullivan Senior Research Analyst Madhu Sharma, Ph.D. "Nonetheless, Carl Zeiss Meditec has responded by implementing an innovation-centric strategy focused on continually presenting novel products and thereby, maintaining a dominant market position."
The company's OCT systems are one of the most widely adopted clinical tools among ophthalmologists. The Stratus OCT(TM) and new Cirrus(TM) HD-OCT systems offer proficiencies and streamlined workflows that allow physicians to gather and interpret detailed disease information.
Additionally, the company has developed proprietary image analysis algorithms that provide volumetric data and aid in interpreting three dimensional images in a highly reproducible and quantitative fashion. It continues to invest in upgrading software for objective measurement and subjective clinical evaluation of retinal disease detection. T
|SOURCE Frost & Sullivan|
Copyright©2009 PR Newswire.
All rights reserved